<DOC>
	<DOCNO>NCT02711579</DOCNO>
	<brief_summary>purpose study evaluate acute electrophysiological response brain cortex single oral dose celecoxib ( 400mg ) healthy volunteer electrophysiological alteration brain cortex long-term treatment celecoxib ( 200mg twice-daily 7 day ) healthy volunteer</brief_summary>
	<brief_title>Impact Celecoxib Electrophysiological Property Brain Healthy Volunteer</brief_title>
	<detailed_description>Inflammatory response consider defense mechanism physical infectious insult also prevail within central nervous system . Following certain kind brain injury ( i.e trauma , ischemia , hypoxia seizure ) , innate immunity subsequent adaptive immunity subserve robust inflammatory cascade , lead excitatory synaptic network . Cellular element , neuron , microglia well inflammatory molecule ( cyclooxygenase2 , interleukin-1 , tumor necrosis factor-alpha , etc ) play essential role enhance process . In line , compel evidence animal study epilepsy field indicate celecoxib ( COX-2 inhibitor ) anticonvulsant action , although mechanism fully understood . Thus , oral administration Celecoxib human high potential suppress neuronal excitability . As milestone big picture , current study go prove change cortical excitability evoke transmagnetic stimulation ( TMS ) electroencephalographic property reveal EEG healthy volunteer , give power spectral analysis EEG several parameter TMS , detect small change neuronal activity celecoxib .</detailed_description>
	<mesh_term>Celecoxib</mesh_term>
	<mesh_term>Cyclooxygenase 2 Inhibitors</mesh_term>
	<criteria>Healthy male female age 20 50 year . Signed voluntary write informed consent . Body mass index 16.0 30.0 kg/m2 . History cardiovascular disease ( i.e . Heart disease , Stroke ) , hepatic disease , inflammatory bowel disease , gastrointestinal hemorrhage , seizure ( ) . History hypersensitivity medication ( ) ( i.e . urticaria , angioedema , shock ) History kind medication ( ) within 1 week screening . Presence clinically significant electrocardiogram abnormality screening . aspartate transaminase alanine transaminase : great 2.0 × upper normal limit . Serum creatinine level : great 1.5 × upper normal limit . Platelet count low 100,000 / μL Serum potassium : great 5.5 mmol/L Female pregnant , breastfeeding , intend become pregnant . History noncompliance medication . History alcohol abuse . Participation drug study within 30 day screen . Galactose intolerance</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>